OPK - オプコ・ヘルス (Opko Health Inc.)

OPKのニュース

   OPKO Health: A Great Long-Term Investment In Health  2022/04/05 22:11:01 Seeking Alpha
   Opko Health – Consensus Indicates Potential 94.4% Upside  2022/04/01 12:20:59 DirectorsTalk
Opko Health with ticker code (OPK) now have 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 8.5 and 5.5 calculating the average target price we see 6.88. Now with the previous closing price of 3.54 this would indicate that there is a potential upside of 94.4%. There is a 50 day moving average of 3.28 and the 200 day moving average is 3.77. The market capitalisation for the company is $2,344m. Company Website: https://www.opko.com [stock_market_widget type="chart" template="basic" color="green" assets="OPK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,556m based on the market concensus. OPKO Health, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.
   OPKO Health Is Risky But Might Make You Money  2022/03/29 22:39:09 Seeking Alpha
   OPKO Health CEO raises his take at the company further (NASDAQ:OPK)  2022/03/15 16:43:36 Seeking Alpha
COVID-19 test maker, OPKO Health <> is trading higher on Tuesday after Chief Executive and Chairman, Dr
   OPKO Health''s unit, Saol Therapeutics team up to detect patients with rare disease  2022/03/01 11:27:03 Seeking Alpha
Saol Therapeutics is collaborating with OPKO Health''s (OPK) unit GeneDx to help in identifying patients diagnosed with a rare mitochondrial disease, Pyruvate Dehydrogenase…
   OPKO Health: A Great Long-Term Investment In Health  2022/04/05 22:11:01 Seeking Alpha
   Opko Health – Consensus Indicates Potential 94.4% Upside  2022/04/01 12:20:59 DirectorsTalk
Opko Health with ticker code (OPK) now have 4 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 8.5 and 5.5 calculating the average target price we see 6.88. Now with the previous closing price of 3.54 this would indicate that there is a potential upside of 94.4%. There is a 50 day moving average of 3.28 and the 200 day moving average is 3.77. The market capitalisation for the company is $2,344m. Company Website: https://www.opko.com [stock_market_widget type="chart" template="basic" color="green" assets="OPK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,556m based on the market concensus. OPKO Health, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.
   OPKO Health Is Risky But Might Make You Money  2022/03/29 22:39:09 Seeking Alpha
   OPKO Health CEO raises his take at the company further (NASDAQ:OPK)  2022/03/15 16:43:36 Seeking Alpha
COVID-19 test maker, OPKO Health <> is trading higher on Tuesday after Chief Executive and Chairman, Dr
   OPKO Health''s unit, Saol Therapeutics team up to detect patients with rare disease  2022/03/01 11:27:03 Seeking Alpha
Saol Therapeutics is collaborating with OPKO Health''s (OPK) unit GeneDx to help in identifying patients diagnosed with a rare mitochondrial disease, Pyruvate Dehydrogenase…
   Important Factors to Analyze A Good Investment: OPKO Health, Inc. (NASDAQ:OPK), Great Panther Mining Limited (AMEX:GPL)  2021/06/29 22:55:26 Stock Equity
OPKO Health, Inc. (OPK) with the stream of 3.71% also noticed, India Great Panther Mining Limited (GPL) encountered a rapid change of -3.43% in the last hour of Tuesdays trading The post Important Factors to Analyze A Good Investment: OPKO Health, Inc. (NASDAQ:OPK), Great Panther Mining Limited (AMEX:GPL) appeared first on Stocks Equity .
   Prostate Cancer Diagnostics Market 2021 Overwhelming Extensive Business Opportunities by Maintaining A Strong Outlook Till 2028 | Top Key Players: MDxHealth,3D Signatures,Genomic Health,Abbott,OPKO Health, INC & More  2021/06/28 21:48:00 iCrowdNewswire
The Insight Partners announces the research on Global Prostate Cancer Diagnostics Market as it covers the key boundaries required for your Research Need. This Global Prostate Cancer Diagnostics Market Report []
   Global Clinical Laboratory Tests Market 2021 COVID-19 Impact Analysis, Demand, Growth, Technology Trends, Key Findings And Forecasts By 2028 || Abbott ARUP Laboratories OPKO Health, Inc. Bioscientia Institute for Medical Diagnostics GmbH  2021/06/23 03:23:17 OpenPR
Global Clinical Laboratory Tests Market report is a complete overview of the market that covers various aspects of product definition, market segmentation based on various parameters, and the existing vendor landscape. Company snapshot, geographical presence, product portfolio, and recent developments
   OPKO Health subsidiary partners with Royal Caribbean for COVID-19 testing program  2021/06/22 12:17:20 Seeking Alpha
   OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx  2021/06/22 12:00:00 OPKO Health
MIAMI, June 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President

calendar